SOFINICLINE (ABT-894 ) FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder.

Saved in:
Bibliographic Details
Main Authors BAIN, EARLE E, AWNI, WALID M, GARIMELLA, TUSHAR S, ABI-SAAB, WALID M, SALTARELLI, MARIO D, DUTTA, SANDEEP
Format Patent
LanguageEnglish
French
Published 10.12.2009
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract 3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder.
AbstractList 3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder.
Author ABI-SAAB, WALID M
DUTTA, SANDEEP
AWNI, WALID M
GARIMELLA, TUSHAR S
SALTARELLI, MARIO D
BAIN, EARLE E
Author_xml – fullname: BAIN, EARLE E
– fullname: AWNI, WALID M
– fullname: GARIMELLA, TUSHAR S
– fullname: ABI-SAAB, WALID M
– fullname: SALTARELLI, MARIO D
– fullname: DUTTA, SANDEEP
BookMark eNrjYmDJy89L5WRwDvZ38_TzdPbx9HNV0HB0CtG1sDRR0FRw8w9ScAwJcfUL8fT303VxdfN09gzR94gMcA1ydA7xDPMMiVRw8Qz2D3JxDeJhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkbmRqYm5gaOhsZEKAEAusEscw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate SOFINICLINE (ABT-894) POUR DES TROUBLES DE DEFICIT DE L'ATTENTION/HYPERACTIVITE
ExternalDocumentID CA2725470A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2725470A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:57:45 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2725470A13
Notes Application Number: CA20092725470
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091210&DB=EPODOC&CC=CA&NR=2725470A1
ParticipantIDs epo_espacenet_CA2725470A1
PublicationCentury 2000
PublicationDate 20091210
PublicationDateYYYYMMDD 2009-12-10
PublicationDate_xml – month: 12
  year: 2009
  text: 20091210
  day: 10
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies ABBOTT LABORATORIES
RelatedCompanies_xml – name: ABBOTT LABORATORIES
Score 2.760323
Snippet 3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SOFINICLINE (ABT-894 ) FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091210&DB=EPODOC&locale=&CC=CA&NR=2725470A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOqbokbwI30wiz4ssC_GHhYzui7UyCBQCTyRdYyEl0Fkxn_f6wLoi741bXK5Nrne_a73uwI8Lhyp6FNLvYPoBwFK29SltDw9NRCyoL_3DKlSA_243Xu3X6fOtAKrPRem7BP6VTZHRItK0d6L8r7e_CSxwrK2ctuUK5xav0TCD7U9OvZUPywt7PpsOAgHVKPUp4EWj3zTRSTktgIESkcYRbuq-otNuoqUsvntUaJzOB6isLy4gEqW1-CU7j9eq8FJf_fejcOd6W0vgY4HEY85feMxI09BV-gdzybPBFEcCYRgsco16SGLOOWi2ZsN2UgViEy4mJGQjxHrsdEVkIgJ2tNRm_lh53MaHPS2rqGar_PsBsgy6ViJnaboWtp2opi01kKaGFdkrpFlTqsO9T_FNP5Zu4Uzc_c7gtG6g2rx8Zndo8st5EN5WN8pmn3Q
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNeJNUSM-92AaPTTQB9AeGlO223QVCoGVwImwpSRcCpEa_76zDaAXvW12k8nMJrMz3-w8AB7nDanKpxa6g-gHAUrT1KW0XD0xELKgvXcNqUID3bgZvduv48a4BMtdLUzRJ_SraI6IGpWgvufFe73-CWIFRW7lpiaXuLV6CYUXaDt07Kp-WFrQ9li_F_SoRqlHfS0eeGYLkVCr7iNQOkQP21Ft9tmorYpS1r8tSngKR30kluVnUEqzCpTpbvBaBY672_9uXG5Vb3MOdNgLecxph8eMPPltoTuuTZ4JojjiC8FiFWvSAxZyykUtmvTZQCWIjLiYkIAPEeuxwQWQkAka6cjNdC_5lPp7vq1LOMhWWXoFZDFzrJmdJGhamvZMVdJac2miX5G2jDRt1KtQ_ZPM9T9nD1CORLczRUHebuDE3E5KMOq3cJB_fKZ3aH5zeV9c3Dc4JIDA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SOFINICLINE+%28ABT-894+%29+FOR+ATTENTION-DEFICIT%2FHYPERACTIVITY+DISORDER&rft.inventor=BAIN%2C+EARLE+E&rft.inventor=AWNI%2C+WALID+M&rft.inventor=GARIMELLA%2C+TUSHAR+S&rft.inventor=ABI-SAAB%2C+WALID+M&rft.inventor=SALTARELLI%2C+MARIO+D&rft.inventor=DUTTA%2C+SANDEEP&rft.date=2009-12-10&rft.externalDBID=A1&rft.externalDocID=CA2725470A1